Danish pharma huge Novo Nordisk teased promising early-phase demo effects of its experimental weight loss capsule amycretin, sending the company’s stock surging.Just after Novo Nordisk’s blockbuster weight loss drug Wegovy produced its debut in Asia by launching in Japan past month, the pharma corporation says it now expects the drug to be appr